Cargando…
Tissue Engineering in Liver Regenerative Medicine: Insights into Novel Translational Technologies
Organ and tissue shortage are known as a crucially important public health problem as unfortunately a small percentage of patients receive transplants. In the context of emerging regenerative medicine, researchers are trying to regenerate and replace different organs and tissues such as the liver, h...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7072533/ https://www.ncbi.nlm.nih.gov/pubmed/32012725 http://dx.doi.org/10.3390/cells9020304 |
_version_ | 1783506428589244416 |
---|---|
author | Heydari, Zahra Najimi, Mustapha Mirzaei, Hamed Shpichka, Anastasia Ruoss, Marc Farzaneh, Zahra Montazeri, Leila Piryaei, Abbas Timashev, Peter Gramignoli, Roberto Nussler, Andreas Baharvand, Hossein Vosough, Massoud |
author_facet | Heydari, Zahra Najimi, Mustapha Mirzaei, Hamed Shpichka, Anastasia Ruoss, Marc Farzaneh, Zahra Montazeri, Leila Piryaei, Abbas Timashev, Peter Gramignoli, Roberto Nussler, Andreas Baharvand, Hossein Vosough, Massoud |
author_sort | Heydari, Zahra |
collection | PubMed |
description | Organ and tissue shortage are known as a crucially important public health problem as unfortunately a small percentage of patients receive transplants. In the context of emerging regenerative medicine, researchers are trying to regenerate and replace different organs and tissues such as the liver, heart, skin, and kidney. Liver tissue engineering (TE) enables us to reproduce and restore liver functions, fully or partially, which could be used in the treatment of acute or chronic liver disorders and/or generate an appropriate functional organ which can be transplanted or employed as an extracorporeal device. In this regard, a variety of techniques (e.g., fabrication technologies, cell-based technologies, microfluidic systems and, extracorporeal liver devices) could be applied in tissue engineering in liver regenerative medicine. Common TE techniques are based on allocating stem cell-derived hepatocyte-like cells or primary hepatocytes within a three-dimensional structure which leads to the improvement of their survival rate and functional phenotype. Taken together, new findings indicated that developing liver tissue engineering-based techniques could pave the way for better treatment of liver-related disorders. Herein, we summarized novel technologies used in liver regenerative medicine and their future applications in clinical settings. |
format | Online Article Text |
id | pubmed-7072533 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-70725332020-03-19 Tissue Engineering in Liver Regenerative Medicine: Insights into Novel Translational Technologies Heydari, Zahra Najimi, Mustapha Mirzaei, Hamed Shpichka, Anastasia Ruoss, Marc Farzaneh, Zahra Montazeri, Leila Piryaei, Abbas Timashev, Peter Gramignoli, Roberto Nussler, Andreas Baharvand, Hossein Vosough, Massoud Cells Review Organ and tissue shortage are known as a crucially important public health problem as unfortunately a small percentage of patients receive transplants. In the context of emerging regenerative medicine, researchers are trying to regenerate and replace different organs and tissues such as the liver, heart, skin, and kidney. Liver tissue engineering (TE) enables us to reproduce and restore liver functions, fully or partially, which could be used in the treatment of acute or chronic liver disorders and/or generate an appropriate functional organ which can be transplanted or employed as an extracorporeal device. In this regard, a variety of techniques (e.g., fabrication technologies, cell-based technologies, microfluidic systems and, extracorporeal liver devices) could be applied in tissue engineering in liver regenerative medicine. Common TE techniques are based on allocating stem cell-derived hepatocyte-like cells or primary hepatocytes within a three-dimensional structure which leads to the improvement of their survival rate and functional phenotype. Taken together, new findings indicated that developing liver tissue engineering-based techniques could pave the way for better treatment of liver-related disorders. Herein, we summarized novel technologies used in liver regenerative medicine and their future applications in clinical settings. MDPI 2020-01-27 /pmc/articles/PMC7072533/ /pubmed/32012725 http://dx.doi.org/10.3390/cells9020304 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Heydari, Zahra Najimi, Mustapha Mirzaei, Hamed Shpichka, Anastasia Ruoss, Marc Farzaneh, Zahra Montazeri, Leila Piryaei, Abbas Timashev, Peter Gramignoli, Roberto Nussler, Andreas Baharvand, Hossein Vosough, Massoud Tissue Engineering in Liver Regenerative Medicine: Insights into Novel Translational Technologies |
title | Tissue Engineering in Liver Regenerative Medicine: Insights into Novel Translational Technologies |
title_full | Tissue Engineering in Liver Regenerative Medicine: Insights into Novel Translational Technologies |
title_fullStr | Tissue Engineering in Liver Regenerative Medicine: Insights into Novel Translational Technologies |
title_full_unstemmed | Tissue Engineering in Liver Regenerative Medicine: Insights into Novel Translational Technologies |
title_short | Tissue Engineering in Liver Regenerative Medicine: Insights into Novel Translational Technologies |
title_sort | tissue engineering in liver regenerative medicine: insights into novel translational technologies |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7072533/ https://www.ncbi.nlm.nih.gov/pubmed/32012725 http://dx.doi.org/10.3390/cells9020304 |
work_keys_str_mv | AT heydarizahra tissueengineeringinliverregenerativemedicineinsightsintonoveltranslationaltechnologies AT najimimustapha tissueengineeringinliverregenerativemedicineinsightsintonoveltranslationaltechnologies AT mirzaeihamed tissueengineeringinliverregenerativemedicineinsightsintonoveltranslationaltechnologies AT shpichkaanastasia tissueengineeringinliverregenerativemedicineinsightsintonoveltranslationaltechnologies AT ruossmarc tissueengineeringinliverregenerativemedicineinsightsintonoveltranslationaltechnologies AT farzanehzahra tissueengineeringinliverregenerativemedicineinsightsintonoveltranslationaltechnologies AT montazerileila tissueengineeringinliverregenerativemedicineinsightsintonoveltranslationaltechnologies AT piryaeiabbas tissueengineeringinliverregenerativemedicineinsightsintonoveltranslationaltechnologies AT timashevpeter tissueengineeringinliverregenerativemedicineinsightsintonoveltranslationaltechnologies AT gramignoliroberto tissueengineeringinliverregenerativemedicineinsightsintonoveltranslationaltechnologies AT nusslerandreas tissueengineeringinliverregenerativemedicineinsightsintonoveltranslationaltechnologies AT baharvandhossein tissueengineeringinliverregenerativemedicineinsightsintonoveltranslationaltechnologies AT vosoughmassoud tissueengineeringinliverregenerativemedicineinsightsintonoveltranslationaltechnologies |